Back to FDA Applications sponsored by GALDERMA LABS LP

FDA Drug Application 022502 by GALDERMA LABS LP

Application Number022502
Application Type New Drug Application
Sponsor ApplicantGALDERMA LABS LP
Most Recent Label Available Flag
Current Patent Flag
Action Type Approval
Chemical Type New formulation
Therapeutic Potential Standard
Orphan Code 


  
Action TypeDuplicate CounterAction DateDocument TypeApplication Document IDSequence NumberDocument TitleDocument URLDocument Date
AP03/17/2010N25075000   http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/022502lbl.pdf 3/18/2010
AP03/17/2010N25084000   http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2010/022502s000ltr.pdf 3/22/2010
AP03/17/2010N26309000   http://www.accessdata.fda.gov/drugsatfda_docs/nda/2010/022502_differin_toc.cfm 8/30/2010
AP03/17/2010N26310000   http://www.accessdata.fda.gov/drugsatfda_docs/nda/2010/022502s000SumR.pdf 8/30/2010
AP04/19/2013SLR35770003   http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/022502Orig1s003ltr.pdf 4/23/2013
AP04/19/2013SLR35811003   http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022502s003lbl.pdf 4/23/2013
AP05/29/2014SCM       
AP09/30/2014SCM       




Back to FDA Applications sponsored by GALDERMA LABS LP